Clinton picks his science adviser
Article Abstract:
President-elect Clinton has chosen Office of Technology Assessment Dir John Gibbons to be his White House science advisor. Gibbons is expected to work closely with vice president-elect Al Gore in his new post since Gore will be in charge of much of the new administration's science policy.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Clinton's technology policy emerges
Article Abstract:
Clinton has indicated that 10% of the proposed $100 billion additional government spending between 1993 and 1997 will go to science and technology programs, although cuts in these programs will also be made. The impact of Clinton's plan on several research projects is discussed.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Jack Gibbons: plugging into the power structure
Article Abstract:
Jack Gibbons forecasts a re-evaluation of federal policy toward technology and basic science and warns that researchers should not expect previous levels of funding to be continued. Funding for the space station and the Superconducting Super Collider has not yet been decided.
Publication Name: Science
Subject: Science and technology
ISSN: 0036-8075
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Gene transfer test: so far, so good. Gene therapy: into the home stretch. Gene therapy clears first hurdle
- Abstracts: Wrapping up science and art. Wildfire. Science books for young people
- Abstracts: Japanese science funding. Science policy in Japan. Public and private support of basic research in Japan
- Abstracts: The sinister cosmos: a meteorite yields clues to life's molecular handedness. Off to an early start
- Abstracts: HHS: Gallo guilty of misconduct. Stubborn HIV reservoirs vulnerable to new treatments. Eradicating HIV from a patient: not just a dream?